United Therapeutics reported $520.2M in Trade Creditors for its fiscal quarter ending in September of 2026.





Trade Creditors Change Date
Amarin USD 40.43M 21.63M Sep/2026
Ardelyx USD 33.66M 4.75M Sep/2026
Baxter International USD 1.02B 10M Sep/2026
Bayer EUR 6.71B 314M Sep/2026
BioCryst Pharmaceuticals USD 14.58M 3.12M Sep/2026
Biogen USD 430.3M 26.4M Sep/2026
BioMarin Pharmaceutical USD 946.11M 32.44M Sep/2026
Emergent BioSolutions USD 112.2M 500K Dec/2023
Gilead Sciences USD 934M 260M Sep/2026
GlaxoSmithKline GBP 15.63B 1.29B Sep/2026
Halozyme Therapeutics USD 33.55M 9.94M Sep/2026
Insmed USD 84.3M 9.75M Sep/2026
Ionis Pharmaceuticals USD 27.11M 20.59M Sep/2026
J&J USD 9.32B 94M Sep/2026
Lexicon Pharmaceuticals USD 3M 87K Mar/2026
Moderna USD 259M 92M Sep/2026
Omeros USD 8.84M 4.42M Jun/2025
Pfizer USD 4.07B 511M Sep/2026
PTC Therapeutics USD 41.59M 1.14M Sep/2026
Regeneron Pharmaceuticals USD 1.14B 19M Sep/2026
Sangamo BioSciences USD 10.74M 7.46M Jun/2025
Sarepta Therapeutics USD 45.7M 5.28M Sep/2026
Teva Pharmaceutical Industries USD 2.55B 170M Sep/2026
United Therapeutics USD 520.2M 22.4M Sep/2026
Vertex Pharmaceuticals USD 3.71B 99.2M Sep/2026